{"gene":"ADD2","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1987,"finding":"Adducin (comprising alpha and beta subunits) bundles actin filaments, promotes spectrin binding to actin independently of protein 4.1, and this activity is down-regulated by calmodulin in a calcium-dependent fashion. The smaller subunit (beta) binds calmodulin in a calcium-dependent manner.","method":"Sedimentation, electrophoretic, and morphologic techniques; purified protein reconstitution","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified components, multiple orthogonal methods","pmids":["3693401"],"is_preprint":false},{"year":1991,"finding":"Human beta-adducin (726 aa) has three structural domains: an N-terminal globular head, a neck, and a C-terminal hydrophilic tail containing a MARCKS-related basic stretch. The tail mediates spectrin-actin interactions and predicted PKC phosphorylation sites are at the C-terminus and head-tail junction. Beta-adducin shows tissue-specific mRNA expression in contrast to ubiquitous alpha-adducin.","method":"cDNA sequencing, Northern blot, EM visualization of tail domain","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — primary sequence determination with domain architecture validated by proteolysis and EM","pmids":["1840603"],"is_preprint":false},{"year":1995,"finding":"Adducin forms heterodimers and tetramers in solution. The C-terminal tail domains of both alpha- and beta-adducin subunits are sufficient for binding spectrin-actin complexes and recruiting additional spectrin molecules; the tail domains adopt a random coil configuration.","method":"Cross-linking, proteolysis, blot-binding, CD spectroscopy of recombinant C-terminal domains","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biochemical methods with recombinant domains and mutagenesis-equivalent domain dissection","pmids":["7642559"],"is_preprint":false},{"year":1996,"finding":"Adducin caps the barbed (fast-growing) ends of actin filaments (Kcap ~100 nM), blocking elongation and depolymerization. This capping activity requires the intact adducin molecule and is down-regulated by calmodulin in the presence of calcium. The short erythrocyte actin filaments are associated with stoichiometric amounts of adducin, consistent with adducin being the functional barbed-end capper in erythrocytes.","method":"Pyrene-actin polymerization assay, barbed-end elongation assay, domain truncation experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with quantitative kinetics and domain dissection","pmids":["8626479"],"is_preprint":false},{"year":1996,"finding":"Ser-713 in the C-terminal MARCKS-related domain of beta-adducin is the major phosphorylation site shared by PKA and PKC. Phosphorylation by PKA (but not PKC) reduces adducin's affinity for spectrin-F-actin complexes. The MARCKS-related domain of beta-adducin is the dominant Ca2+-dependent calmodulin-binding site, and calmodulin binding is inhibited by phosphorylation of beta-adducin by PKA or PKC.","method":"Site-directed mutagenesis, phosphopeptide mapping, in vitro kinase assays, spectrin-actin binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — site-specific mutagenesis combined with functional binding assays, replicated across subunits","pmids":["8810272"],"is_preprint":false},{"year":1998,"finding":"PKC phosphorylation of the MARCKS-related domain of adducin (at Ser-716/Ser-726 of alpha; equivalent site on beta) inhibits actin capping activity and abolishes adducin-mediated recruitment of spectrin to actin filament ends and sides. Adducin is a prominent in vivo PKC substrate in multiple cell types including neurons. Phospho-adducin localizes to dendritic spines and cell-cell contact sites; PKC-unphosphorylatable alpha-adducin mutant mislocalizes from the membrane to cytoplasmic puncta and causes cytoplasmic spectrin accumulation.","method":"Pyrene-actin polymerization assay, phosphospecific antibody, immunofluorescence, stable transfection of MDCK cells with S716A/S726A mutant, PMA treatment of multiple cell types","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution plus mutagenesis plus in vivo functional validation across multiple cell types","pmids":["9679146"],"is_preprint":false},{"year":1999,"finding":"Loss of beta-adducin in mice causes red blood cell spherocytosis: null RBCs are osmotically fragile, spherocytic, and dehydrated. Beta-adducin absence reduces membrane incorporation of alpha-adducin to 30% of normal and causes a 5-fold compensatory increase in gamma-adducin incorporation into the RBC membrane skeleton, demonstrating adducin's essential role in RBC membrane stability in vivo.","method":"Gene targeting (exon 9–13 deletion), osmotic fragility assays, membrane protein quantification, Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular phenotype and molecular quantification, highly cited","pmids":["10485892"],"is_preprint":false},{"year":2004,"finding":"Hypertensive adducin variant expression in renal epithelial cells impairs dopamine-stimulated Na+,K+-ATPase endocytosis by causing hyperphosphorylation of adaptin mu2 subunit, preventing adaptin-Na+,K+-ATPase interaction and thus increasing renal Na+,K+-ATPase activity and sodium reabsorption. This mechanism links adducin mutation to abnormal sodium handling in hypertension.","method":"Expression of hypertensive rat/human adducin variant in normal renal epithelial cells, Na+,K+-ATPase activity assay, co-immunoprecipitation, mu2 phosphorylation assay","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — functional reconstitution in cell line with biochemical readouts, single lab","pmids":["15528469"],"is_preprint":false},{"year":2008,"finding":"Adducin directly interacts with glucose transporter-1 (GLUT1) at the erythrocyte membrane, providing a physical link between the spectrin-actin junctional complex and the lipid bilayer. This interaction was identified using surface labeling, co-immunoprecipitation, and vesicle proteomics.","method":"Surface labeling, co-immunoprecipitation, vesicle proteomics","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal co-IP and proteomics but single lab; finding places adducin as a transmembrane anchor","pmids":["18347014"],"is_preprint":false},{"year":2009,"finding":"Beta-adducin KO mice display deficits in hippocampal LTP and LTD, impaired learning and motor coordination, and altered expression/phosphorylation of alpha- and gamma-adducin in brain regions. Beta-adducin mRNA is localized to dendrites, suggesting local translational regulation of synaptic plasticity.","method":"Beta-adducin KO mouse model, electrophysiology (LTP/LTD), behavioral assays, Western blot, in situ hybridization for dendritic mRNA","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with electrophysiological and behavioral phenotyping, multiple readouts","pmids":["19900187"],"is_preprint":false},{"year":2013,"finding":"The distal brain-specific polyadenylation site (PAS4) of Add2 pre-mRNA requires both a hexanucleotide motif and a downstream sequence element (DSE) containing UG repeats for efficient 3' end processing. RNA-protein complexes form on the DSE; proteins PTB, TDP-43, FBP1, FBP2, nucleolin, RNA helicase A, and vigilin were identified as DSE-binding proteins. Two novel long-distance cis-acting elements (>4.5 kb upstream of PAS4) regulate Add2 3' end processing.","method":"Chimeric minigene transfection, deletion/point mutagenesis, RNA-EMSA, RNA pulldown with mass spectrometry identification","journal":"PloS one / RNA biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — minigene mutagenesis plus RNA-protein interaction assays, single lab","pmids":["23554949","23411391"],"is_preprint":false},{"year":2014,"finding":"TDP-43 regulates Add2 mRNA stability: TDP-43 depletion decreases Add2 transcript levels in HeLa and HEK293 cells. The effect is not mediated via TDP-43 binding to the DSE or via modulation of 3' end cleavage/polyadenylation, but rather through post-transcriptional stabilization of the Add2 mRNA.","method":"TDP-43 siRNA knockdown, chimeric minigene assays, RNA-EMSA, polyA tail length analysis, co-immunoprecipitation with polyadenylation factors","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in two cell lines ruling out alternative mechanisms, single lab","pmids":["25602706"],"is_preprint":false},{"year":2019,"finding":"miR-218 suppresses migration and invasion of endometrial cancer cells by directly targeting the 3'UTR of ADD2 mRNA and negatively regulating ADD2 protein expression, as validated by luciferase reporter assay and rescue experiments.","method":"Luciferase reporter assay, Western blot, wound healing assay, Matrigel invasion assay, rescue experiments","journal":"European review for medical and pharmacological sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct 3'UTR targeting validated by reporter assay with functional rescue, single lab","pmids":["30840261"],"is_preprint":false}],"current_model":"Beta-adducin (ADD2) is a cytoskeletal scaffolding protein that, as part of alpha/beta heterodimers and tetramers, caps barbed ends of actin filaments, bundles actin, and recruits spectrin to actin filament ends via its C-terminal MARCKS-related tail domain; these activities are inhibited by PKC/PKA phosphorylation at Ser-713 and by Ca2+/calmodulin binding to the MARCKS domain, and in vivo ADD2 is required for erythrocyte membrane stability, synaptic plasticity (LTP/LTD), and links the spectrin-actin junctional complex to GLUT1 at the plasma membrane, while its mRNA stability is regulated post-transcriptionally by TDP-43."},"narrative":{"teleology":[{"year":1987,"claim":"The first reconstitution of adducin activity established that alpha/beta adducin bundles actin, promotes spectrin–actin association independently of protein 4.1, and is negatively regulated by Ca²⁺/calmodulin, defining adducin as a regulated cytoskeletal scaffold.","evidence":"Purified human erythrocyte adducin characterized by sedimentation, electrophoresis, and morphologic assays","pmids":["3693401"],"confidence":"High","gaps":["Stoichiometry and capping versus bundling contributions were not separated","In vivo relevance in intact erythrocytes not yet demonstrated"]},{"year":1991,"claim":"Cloning and domain mapping of beta-adducin revealed a three-domain architecture (head–neck–tail) with a C-terminal MARCKS-related domain responsible for spectrin-actin interaction and predicted PKC phosphorylation sites, establishing the structural basis for regulated cytoskeletal function.","evidence":"cDNA sequencing, Northern blot tissue expression, rotary-shadowed EM of recombinant domains","pmids":["1840603"],"confidence":"High","gaps":["Phosphorylation sites were predicted but not functionally validated","No high-resolution structure of the head or neck domain"]},{"year":1995,"claim":"Demonstration that adducin forms heterodimers/tetramers and that isolated C-terminal tail domains are sufficient for spectrin–actin recruitment resolved which portion of the molecule mediates the key scaffolding function.","evidence":"Cross-linking, proteolysis, blot-binding, and CD spectroscopy of recombinant tail domains","pmids":["7642559"],"confidence":"High","gaps":["How head domain contributes to in vivo assembly remained unclear","No crystal or NMR structure of the tail–spectrin–actin ternary complex"]},{"year":1996,"claim":"Quantitative barbed-end capping activity of adducin (Kcap ~100 nM) was defined, and this activity was shown to be inhibited by Ca²⁺/calmodulin; separately, Ser-713 of beta-adducin was identified as the shared PKA/PKC site whose phosphorylation reduces spectrin–actin affinity, providing a dual regulatory switch for adducin function.","evidence":"Pyrene-actin polymerization kinetics, site-directed mutagenesis, phosphopeptide mapping, spectrin–actin binding assays","pmids":["8626479","8810272"],"confidence":"High","gaps":["Relative contributions of PKA vs PKC phosphorylation in vivo were unknown","Structural basis for how phosphorylation disrupts spectrin–actin binding unresolved"]},{"year":1998,"claim":"PKC phosphorylation of adducin's MARCKS domain was shown to abolish both barbed-end capping and spectrin recruitment in vitro and in vivo, and phospho-adducin was localized to dendritic spines and cell–cell contacts, expanding adducin's regulated role beyond erythrocytes to epithelial and neuronal cells.","evidence":"Pyrene-actin assays, phosphospecific antibody immunofluorescence, stable expression of phospho-dead alpha-adducin in MDCK cells","pmids":["9679146"],"confidence":"High","gaps":["Whether beta-adducin phosphorylation produces identical in vivo phenotypes was not tested","Kinetics and reversibility of PKC regulation in neurons not characterized"]},{"year":1999,"claim":"Genetic ablation of beta-adducin in mice produced hereditary spherocytosis with osmotically fragile red cells and a compensatory 5-fold increase in gamma-adducin, proving ADD2 is essential for erythrocyte membrane skeletal integrity.","evidence":"Targeted deletion of exons 9–13 in mice; osmotic fragility assays, Western blot quantification of membrane adducin subunits","pmids":["10485892"],"confidence":"High","gaps":["Whether gamma-adducin compensation is functionally equivalent was not determined","Human disease counterpart had not been established"]},{"year":2004,"claim":"Expression of hypertensive adducin variants in renal epithelial cells impaired dopamine-stimulated Na⁺,K⁺-ATPase endocytosis via adaptin mu2 hyperphosphorylation, providing a mechanism linking adducin mutations to renal sodium retention and hypertension.","evidence":"Overexpression of rat/human variant adducin in OK cells, Na⁺,K⁺-ATPase activity and mu2 phosphorylation assays, co-IP","pmids":["15528469"],"confidence":"Medium","gaps":["Single-lab finding; not independently replicated","Which adducin subunit (alpha vs beta) is the primary driver in this pathway was unclear","In vivo renal phenotype not demonstrated in beta-adducin-specific models"]},{"year":2008,"claim":"Identification of a direct adducin–GLUT1 interaction placed adducin as a physical linker between the spectrin–actin junctional complex and the lipid bilayer, resolving a gap in understanding how the erythrocyte membrane skeleton attaches to integral membrane proteins.","evidence":"Surface labeling, co-immunoprecipitation, and vesicle proteomics from human erythrocyte membranes","pmids":["18347014"],"confidence":"Medium","gaps":["Single-lab co-IP; binding domain on adducin not mapped","Functional consequence of disrupting the adducin–GLUT1 link not tested"]},{"year":2009,"claim":"Beta-adducin knockout mice exhibited impaired hippocampal LTP/LTD and behavioral deficits in learning and motor coordination, with dendritic localization of Add2 mRNA suggesting local translational regulation, establishing ADD2 as necessary for synaptic plasticity.","evidence":"Beta-adducin KO mice, field potential electrophysiology, Morris water maze and rotarod behavioral assays, in situ hybridization","pmids":["19900187"],"confidence":"Medium","gaps":["Molecular mechanism connecting adducin loss to LTP/LTD impairment not defined","Whether dendritic mRNA undergoes activity-dependent translation not tested"]},{"year":2013,"claim":"Brain-specific polyadenylation of Add2 pre-mRNA was found to require a UG-rich downstream sequence element bound by TDP-43, PTB, and other RNA-binding proteins, plus long-distance cis elements, revealing a complex layer of tissue-specific post-transcriptional regulation.","evidence":"Chimeric minigene transfection and mutagenesis, RNA-EMSA, RNA pulldown with mass spectrometry","pmids":["23554949","23411391"],"confidence":"Medium","gaps":["Functional contribution of each identified RBP to Add2 processing not individually tested","Whether these cis-elements regulate Add2 processing in primary neurons unknown"]},{"year":2014,"claim":"TDP-43 was shown to stabilize Add2 mRNA post-transcriptionally rather than via 3′ end cleavage/polyadenylation, distinguishing its role from the DSE-binding complex identified earlier and linking TDP-43 pathology to cytoskeletal gene regulation.","evidence":"TDP-43 siRNA knockdown in HeLa and HEK293 cells, polyA tail length analysis, RNA-EMSA, co-IP with polyadenylation factors","pmids":["25602706"],"confidence":"Medium","gaps":["Whether TDP-43 directly binds Add2 mRNA or acts via an intermediate is unknown","Relevance to TDP-43 proteinopathy (ALS/FTD) models not tested"]},{"year":null,"claim":"No high-resolution structure of the adducin heterodimer or its ternary complex with spectrin and F-actin has been determined, the molecular mechanism by which adducin loss impairs synaptic plasticity remains undefined, and the human disease spectrum caused by ADD2 mutations is incompletely characterized.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structural model of adducin or its spectrin–actin complex","Molecular mechanism linking adducin to LTP/LTD induction not determined","Human Mendelian phenotype for ADD2 loss-of-function not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,2,3,5]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,3,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,6,8]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,3,5,6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,7]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9]}],"complexes":["adducin alpha/beta heterodimer","spectrin-actin junctional complex"],"partners":["ADD1","ADD3","SPTA1","SPTB","SLC2A1","TARDBP"],"other_free_text":[]},"mechanistic_narrative":"Beta-adducin (ADD2) is a cytoskeletal scaffolding protein that, together with alpha-adducin, forms heterodimers and tetramers to cap barbed ends of actin filaments, bundle actin, and recruit spectrin to actin filament ends and sides via its C-terminal MARCKS-related tail domain [PMID:3693401, PMID:7642559, PMID:8626479]. These activities are negatively regulated by PKC/PKA phosphorylation at Ser-713 and by Ca²⁺/calmodulin binding to the MARCKS domain, which controls adducin's membrane association and spectrin-actin lattice assembly [PMID:8810272, PMID:9679146]. Genetic ablation of ADD2 in mice causes hereditary spherocytosis with osmotically fragile erythrocytes and compensatory gamma-adducin upregulation, and separately produces deficits in hippocampal LTP, LTD, learning, and motor coordination, establishing essential roles in both erythrocyte membrane integrity and synaptic plasticity [PMID:10485892, PMID:19900187]. ADD2 mRNA stability is post-transcriptionally regulated by TDP-43 and brain-specific 3′ end processing elements, and adducin physically links the spectrin-actin junctional complex to GLUT1 at the erythrocyte plasma membrane [PMID:25602706, PMID:18347014]."},"prefetch_data":{"uniprot":{"accession":"P35612","full_name":"Beta-adducin","aliases":["Erythrocyte adducin subunit beta"],"length_aa":726,"mass_kda":80.9,"function":"Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to the erythrocyte membrane receptor SLC2A1/GLUT1 and may therefore provide a link between the spectrin cytoskeleton to the plasma membrane. Binds to calmodulin. Calmodulin binds preferentially to the beta subunit","subcellular_location":"Cytoplasm, cytoskeleton; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35612/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADD2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ADD2","total_profiled":1310},"omim":[{"mim_id":"601568","title":"ADDUCIN 3; ADD3","url":"https://www.omim.org/entry/601568"},{"mim_id":"179490","title":"RAS-ASSOCIATED PROTEIN RAB3A; RAB3A","url":"https://www.omim.org/entry/179490"},{"mim_id":"125305","title":"ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49","url":"https://www.omim.org/entry/125305"},{"mim_id":"102681","title":"ADDUCIN 2; ADD2","url":"https://www.omim.org/entry/102681"},{"mim_id":"102680","title":"ADDUCIN 1; ADD1","url":"https://www.omim.org/entry/102680"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":62.7},{"tissue":"brain","ntpm":36.1}],"url":"https://www.proteinatlas.org/search/ADD2"},"hgnc":{"alias_symbol":["ADDB"],"prev_symbol":[]},"alphafold":{"accession":"P35612","domains":[{"cath_id":"-","chopping":"30-96","consensus_level":"medium","plddt":77.164,"start":30,"end":96},{"cath_id":"3.40.225.10","chopping":"121-324","consensus_level":"high","plddt":91.5759,"start":121,"end":324}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35612","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35612-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35612-F1-predicted_aligned_error_v6.png","plddt_mean":65.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADD2","jax_strain_url":"https://www.jax.org/strain/search?query=ADD2"},"sequence":{"accession":"P35612","fasta_url":"https://rest.uniprot.org/uniprotkb/P35612.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35612/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35612"}},"corpus_meta":[{"pmid":"10485892","id":"PMC_10485892","title":"Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10485892","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19900187","id":"PMC_19900187","title":"beta-adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the alpha- and gamma-adducin subunits.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19900187","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25602706","id":"PMC_25602706","title":"TDP-43 regulates β-adducin (Add2) transcript stability.","date":"2014","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/25602706","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15099822","id":"PMC_15099822","title":"Genotoxicity of 2-[2-(acetylamino)-4-[bis(2-hydroxyethyl)amino]-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole (PBTA-6) and 4-amino-3,3'-dichloro-5,4'-dinitro-biphenyl (ADDB) in goldfish (Carassius auratus) using the micronucleus test and the comet assay.","date":"2004","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/15099822","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9244430","id":"PMC_9244430","title":"Organization of the human beta-adducin gene (ADD2).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9244430","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8752329","id":"PMC_8752329","title":"Effects of lysine-to-glycine mutations in the ATP-binding consensus sequences in the AddA and AddB subunits on the Bacillus subtilis AddAB enzyme activities.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8752329","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12951058","id":"PMC_12951058","title":"Expression analysis of the human adducin gene family and evidence of ADD2 beta4 multiple splicing variants.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12951058","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30840261","id":"PMC_30840261","title":"MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30840261","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15963851","id":"PMC_15963851","title":"Expression of adducin genes during erythropoiesis: a novel erythroid promoter for ADD2.","date":"2005","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/15963851","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23554949","id":"PMC_23554949","title":"Characterization of the distal polyadenylation site of the ß-adducin (Add2) pre-mRNA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23554949","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25785112","id":"PMC_25785112","title":"Common variant rs7597774 in ADD2 is associated with dilated cardiomyopathy in Chinese Han population.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25785112","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17499012","id":"PMC_17499012","title":"Quantification of a potent mutagenic 4-amino-3,3'-dichloro-5,4'-dinitrobiphenyl (ADDB) and the related chemicals in water from the Waka River in Wakayama, Japan.","date":"2007","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/17499012","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23411391","id":"PMC_23411391","title":"Long-distance regulation of Add2 pre-mRNA3'end processing.","date":"2013","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/23411391","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.27.650825","title":"Sludge liquefaction and stratification enable ultra-high digestion rate and resource recovery for waste activated sludge treatment","date":"2025-04-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.27.650825","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889549","id":"PMC_8889549","title":"Generation and analysis of 280,000 human expressed sequence tags.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889549","citation_count":376,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15345747","id":"PMC_15345747","title":"Phosphoproteomic analysis of the developing mouse brain.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/15345747","citation_count":291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35063084","id":"PMC_35063084","title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.","date":"2022","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/35063084","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19460752","id":"PMC_19460752","title":"A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19460752","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9679146","id":"PMC_9679146","title":"Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9679146","citation_count":182,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30442766","id":"PMC_30442766","title":"LZTR1 is a regulator of RAS ubiquitination and signaling.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30442766","citation_count":180,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3693401","id":"PMC_3693401","title":"Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding.","date":"1987","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/3693401","citation_count":171,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8626479","id":"PMC_8626479","title":"A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626479","citation_count":166,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8810272","id":"PMC_8810272","title":"Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8810272","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7642559","id":"PMC_7642559","title":"Adducin: a physical model with implications for function in assembly of spectrin-actin complexes.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642559","citation_count":146,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1840603","id":"PMC_1840603","title":"Primary structure and domain organization of human alpha and beta adducin.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1840603","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21832049","id":"PMC_21832049","title":"Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832049","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30639242","id":"PMC_30639242","title":"The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30639242","citation_count":124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32707033","id":"PMC_32707033","title":"Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32707033","citation_count":88,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15528469","id":"PMC_15528469","title":"Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium.","date":"2004","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15528469","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18347014","id":"PMC_18347014","title":"Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18347014","citation_count":75,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8430,"output_tokens":1630,"usd":0.02487},"stage2":{"model":"claude-opus-4-6","input_tokens":4869,"output_tokens":1570,"usd":0.095393},"total_usd":0.344568,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":21687,"output_tokens":3248,"usd":0.05689},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6852,"output_tokens":3094,"usd":0.167415}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Beta-adducin (ADD2) is required for red blood cell membrane stability in vivo; its absence causes spherocytosis, osmotic fragility, and dehydration. Loss of beta-adducin reduces alpha-adducin incorporation into the RBC membrane skeleton to ~30% of normal and promotes a 5-fold increase in gamma-adducin incorporation, demonstrating that ADD2 regulates the stoichiometric assembly of the adducin complex at the membrane skeleton.\",\n      \"method\": \"Gene targeting (knockout mouse), peripheral blood analysis, membrane protein fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype and quantitative membrane protein fractionation, foundational paper with ~99 citations\",\n      \"pmids\": [\"10485892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Beta-adducin (ADD2) is required for hippocampal long-term potentiation (LTP) and long-term depression (LTD), motor coordination, and learning in vivo. Beta-adducin KO mice show decreased phosphorylation of adducin, reduced alpha-adducin expression, and upregulation of gamma-adducin in hippocampus, cerebellum and neocortex, indicating coordinated phosphorylation and expression of adducin subunits as a mechanism underlying synaptic plasticity. Additionally, Add2 mRNA is located in dendrites, suggesting local translation contributes to synaptic modulation.\",\n      \"method\": \"Beta-adducin knockout mouse model, electrophysiology (LTP/LTD recording), behavioral assays, Western blotting, in situ hybridization\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined synaptic and behavioral phenotype, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"19900187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TDP-43 regulates ADD2 (beta-adducin) gene expression by increasing Add2 mRNA stability. TDP-43 depletion in HeLa and HEK293 cells decreases endogenous Add2 mRNA levels independently of the downstream polyadenylation element (DSE), and TDP-43 does not influence pre-mRNA cleavage or polyA tail length, placing its action at the level of mRNA stability rather than 3' end processing.\",\n      \"method\": \"TDP-43 knockdown in HeLa and HEK293 cells, chimeric minigene assays, RNA stability assays, RNA-EMSA, co-immunoprecipitation (failed for CstF-64/CPSF160)\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (minigene, knockdown, EMSA) in single lab\",\n      \"pmids\": [\"25602706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The distal brain-specific polyadenylation site (PAS4) of Add2 pre-mRNA requires both the hexanucleotide motif and a downstream sequence element (DSE) containing UG repeats for efficient 3' end processing. RNA-pulldown identified proteins binding the DSE including PTB, TDP-43, FBP1, FBP2, nucleolin, RNA helicase A, and vigilin, with PTB having a reported function in polyadenylation.\",\n      \"method\": \"Chimeric minigene transfection, deletion/point mutagenesis of polyadenylation elements, RNA-EMSA, RNA pulldown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis and biochemical pulldown, single lab, multiple complementary approaches\",\n      \"pmids\": [\"23554949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Long-distance upstream cis-acting elements regulate Add2 pre-mRNA 3' end processing at the brain-specific PAS4: one element located >5 kb upstream is essential for PAS4 processing, while a second element ~4.5 kb upstream reduces PAS4 processing, representing the first described long-distance upstream polyadenylation regulatory elements in a non-viral eukaryotic transcript.\",\n      \"method\": \"In vivo minigene transfection assay with deletion mapping of cis elements\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method (minigene transfection), no protein factors identified\",\n      \"pmids\": [\"23411391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-218 directly targets the ADD2 3'UTR, as validated by luciferase reporter assay, and suppresses migration and invasion of endometrial cancer cells by negatively regulating ADD2 protein expression.\",\n      \"method\": \"Luciferase reporter gene assay, Western blotting, wound healing assay, Matrigel invasion assay, qRT-PCR\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, limited mechanistic follow-up beyond reporter assay validation\",\n      \"pmids\": [\"30840261\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADD2 (beta-adducin) is a cytoskeletal protein that assembles with alpha- and gamma-adducin at the erythrocyte membrane skeleton to maintain red blood cell shape and stability, and at neuronal synapses (dendritic spines, growth cones) where its phosphorylation state—regulated in concert with the other adducin subunits—controls actin-spectrin complex dynamics underlying synaptic plasticity (LTP/LTD), motor coordination, and learning; its mRNA is stabilized post-transcriptionally by TDP-43, and its brain-specific isoform is generated through long-distance and proximal cis-element-dependent alternative polyadenylation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"Adducin (comprising alpha and beta subunits) bundles actin filaments, promotes spectrin binding to actin independently of protein 4.1, and this activity is down-regulated by calmodulin in a calcium-dependent fashion. The smaller subunit (beta) binds calmodulin in a calcium-dependent manner.\",\n      \"method\": \"Sedimentation, electrophoretic, and morphologic techniques; purified protein reconstitution\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified components, multiple orthogonal methods\",\n      \"pmids\": [\"3693401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Human beta-adducin (726 aa) has three structural domains: an N-terminal globular head, a neck, and a C-terminal hydrophilic tail containing a MARCKS-related basic stretch. The tail mediates spectrin-actin interactions and predicted PKC phosphorylation sites are at the C-terminus and head-tail junction. Beta-adducin shows tissue-specific mRNA expression in contrast to ubiquitous alpha-adducin.\",\n      \"method\": \"cDNA sequencing, Northern blot, EM visualization of tail domain\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary sequence determination with domain architecture validated by proteolysis and EM\",\n      \"pmids\": [\"1840603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Adducin forms heterodimers and tetramers in solution. The C-terminal tail domains of both alpha- and beta-adducin subunits are sufficient for binding spectrin-actin complexes and recruiting additional spectrin molecules; the tail domains adopt a random coil configuration.\",\n      \"method\": \"Cross-linking, proteolysis, blot-binding, CD spectroscopy of recombinant C-terminal domains\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biochemical methods with recombinant domains and mutagenesis-equivalent domain dissection\",\n      \"pmids\": [\"7642559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Adducin caps the barbed (fast-growing) ends of actin filaments (Kcap ~100 nM), blocking elongation and depolymerization. This capping activity requires the intact adducin molecule and is down-regulated by calmodulin in the presence of calcium. The short erythrocyte actin filaments are associated with stoichiometric amounts of adducin, consistent with adducin being the functional barbed-end capper in erythrocytes.\",\n      \"method\": \"Pyrene-actin polymerization assay, barbed-end elongation assay, domain truncation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with quantitative kinetics and domain dissection\",\n      \"pmids\": [\"8626479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Ser-713 in the C-terminal MARCKS-related domain of beta-adducin is the major phosphorylation site shared by PKA and PKC. Phosphorylation by PKA (but not PKC) reduces adducin's affinity for spectrin-F-actin complexes. The MARCKS-related domain of beta-adducin is the dominant Ca2+-dependent calmodulin-binding site, and calmodulin binding is inhibited by phosphorylation of beta-adducin by PKA or PKC.\",\n      \"method\": \"Site-directed mutagenesis, phosphopeptide mapping, in vitro kinase assays, spectrin-actin binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-specific mutagenesis combined with functional binding assays, replicated across subunits\",\n      \"pmids\": [\"8810272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"PKC phosphorylation of the MARCKS-related domain of adducin (at Ser-716/Ser-726 of alpha; equivalent site on beta) inhibits actin capping activity and abolishes adducin-mediated recruitment of spectrin to actin filament ends and sides. Adducin is a prominent in vivo PKC substrate in multiple cell types including neurons. Phospho-adducin localizes to dendritic spines and cell-cell contact sites; PKC-unphosphorylatable alpha-adducin mutant mislocalizes from the membrane to cytoplasmic puncta and causes cytoplasmic spectrin accumulation.\",\n      \"method\": \"Pyrene-actin polymerization assay, phosphospecific antibody, immunofluorescence, stable transfection of MDCK cells with S716A/S726A mutant, PMA treatment of multiple cell types\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution plus mutagenesis plus in vivo functional validation across multiple cell types\",\n      \"pmids\": [\"9679146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Loss of beta-adducin in mice causes red blood cell spherocytosis: null RBCs are osmotically fragile, spherocytic, and dehydrated. Beta-adducin absence reduces membrane incorporation of alpha-adducin to 30% of normal and causes a 5-fold compensatory increase in gamma-adducin incorporation into the RBC membrane skeleton, demonstrating adducin's essential role in RBC membrane stability in vivo.\",\n      \"method\": \"Gene targeting (exon 9–13 deletion), osmotic fragility assays, membrane protein quantification, Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype and molecular quantification, highly cited\",\n      \"pmids\": [\"10485892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Hypertensive adducin variant expression in renal epithelial cells impairs dopamine-stimulated Na+,K+-ATPase endocytosis by causing hyperphosphorylation of adaptin mu2 subunit, preventing adaptin-Na+,K+-ATPase interaction and thus increasing renal Na+,K+-ATPase activity and sodium reabsorption. This mechanism links adducin mutation to abnormal sodium handling in hypertension.\",\n      \"method\": \"Expression of hypertensive rat/human adducin variant in normal renal epithelial cells, Na+,K+-ATPase activity assay, co-immunoprecipitation, mu2 phosphorylation assay\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution in cell line with biochemical readouts, single lab\",\n      \"pmids\": [\"15528469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Adducin directly interacts with glucose transporter-1 (GLUT1) at the erythrocyte membrane, providing a physical link between the spectrin-actin junctional complex and the lipid bilayer. This interaction was identified using surface labeling, co-immunoprecipitation, and vesicle proteomics.\",\n      \"method\": \"Surface labeling, co-immunoprecipitation, vesicle proteomics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal co-IP and proteomics but single lab; finding places adducin as a transmembrane anchor\",\n      \"pmids\": [\"18347014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Beta-adducin KO mice display deficits in hippocampal LTP and LTD, impaired learning and motor coordination, and altered expression/phosphorylation of alpha- and gamma-adducin in brain regions. Beta-adducin mRNA is localized to dendrites, suggesting local translational regulation of synaptic plasticity.\",\n      \"method\": \"Beta-adducin KO mouse model, electrophysiology (LTP/LTD), behavioral assays, Western blot, in situ hybridization for dendritic mRNA\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with electrophysiological and behavioral phenotyping, multiple readouts\",\n      \"pmids\": [\"19900187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The distal brain-specific polyadenylation site (PAS4) of Add2 pre-mRNA requires both a hexanucleotide motif and a downstream sequence element (DSE) containing UG repeats for efficient 3' end processing. RNA-protein complexes form on the DSE; proteins PTB, TDP-43, FBP1, FBP2, nucleolin, RNA helicase A, and vigilin were identified as DSE-binding proteins. Two novel long-distance cis-acting elements (>4.5 kb upstream of PAS4) regulate Add2 3' end processing.\",\n      \"method\": \"Chimeric minigene transfection, deletion/point mutagenesis, RNA-EMSA, RNA pulldown with mass spectrometry identification\",\n      \"journal\": \"PloS one / RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — minigene mutagenesis plus RNA-protein interaction assays, single lab\",\n      \"pmids\": [\"23554949\", \"23411391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TDP-43 regulates Add2 mRNA stability: TDP-43 depletion decreases Add2 transcript levels in HeLa and HEK293 cells. The effect is not mediated via TDP-43 binding to the DSE or via modulation of 3' end cleavage/polyadenylation, but rather through post-transcriptional stabilization of the Add2 mRNA.\",\n      \"method\": \"TDP-43 siRNA knockdown, chimeric minigene assays, RNA-EMSA, polyA tail length analysis, co-immunoprecipitation with polyadenylation factors\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in two cell lines ruling out alternative mechanisms, single lab\",\n      \"pmids\": [\"25602706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-218 suppresses migration and invasion of endometrial cancer cells by directly targeting the 3'UTR of ADD2 mRNA and negatively regulating ADD2 protein expression, as validated by luciferase reporter assay and rescue experiments.\",\n      \"method\": \"Luciferase reporter assay, Western blot, wound healing assay, Matrigel invasion assay, rescue experiments\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct 3'UTR targeting validated by reporter assay with functional rescue, single lab\",\n      \"pmids\": [\"30840261\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Beta-adducin (ADD2) is a cytoskeletal scaffolding protein that, as part of alpha/beta heterodimers and tetramers, caps barbed ends of actin filaments, bundles actin, and recruits spectrin to actin filament ends via its C-terminal MARCKS-related tail domain; these activities are inhibited by PKC/PKA phosphorylation at Ser-713 and by Ca2+/calmodulin binding to the MARCKS domain, and in vivo ADD2 is required for erythrocyte membrane stability, synaptic plasticity (LTP/LTD), and links the spectrin-actin junctional complex to GLUT1 at the plasma membrane, while its mRNA stability is regulated post-transcriptionally by TDP-43.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ADD2 (beta-adducin) is a cytoskeletal protein that controls the stoichiometric assembly of the adducin heterocomplex at the erythrocyte membrane skeleton; its genetic ablation reduces alpha-adducin membrane incorporation to ~30% of normal while triggering compensatory gamma-adducin upregulation, resulting in spherocytosis, osmotic fragility, and red blood cell dehydration [PMID:10485892]. In the brain, ADD2 is required for hippocampal long-term potentiation and depression, motor coordination, and learning, with its dendritic mRNA suggesting local translation contributes to synaptic modulation [PMID:19900187]. ADD2 mRNA stability is positively regulated by TDP-43 independently of 3′ end processing, and the brain-specific polyadenylation isoform depends on both proximal downstream UG-repeat elements and long-distance upstream cis-regulatory sequences [PMID:25602706, PMID:23554949, PMID:23411391].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"The first in vivo requirement for ADD2 was established: beta-adducin loss destabilizes the erythrocyte membrane skeleton by disrupting the stoichiometric ratio of adducin subunits, answering whether individual adducin subunits are functionally non-redundant.\",\n      \"evidence\": \"Beta-adducin knockout mouse with quantitative membrane protein fractionation and hematological analysis\",\n      \"pmids\": [\"10485892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which gamma-adducin compensates structurally but not functionally is not defined\",\n        \"Whether the RBC phenotype reflects loss of actin-spectrin capping specifically versus general scaffold destabilization is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"ADD2 was shown to be required for synaptic plasticity (LTP and LTD) and behavior (motor coordination, learning), establishing that the adducin-based cytoskeletal mechanism operating in erythrocytes extends to neuronal synapses.\",\n      \"evidence\": \"Beta-adducin knockout mouse with hippocampal electrophysiology, behavioral testing, Western blotting, and in situ hybridization for dendritic mRNA\",\n      \"pmids\": [\"19900187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the synaptic phenotype is cell-autonomous or circuit-level has not been dissected\",\n        \"Specific phosphorylation sites on beta-adducin responsible for synaptic plasticity are not mapped\",\n        \"Contribution of local dendritic translation versus somatic translation to the synaptic pool is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The molecular basis for brain-specific ADD2 mRNA isoform generation was defined: the distal polyadenylation site (PAS4) requires both a proximal UG-repeat downstream sequence element and unprecedented long-distance upstream cis-regulatory elements (>4–5 kb away), revealing a novel mechanism of tissue-specific alternative polyadenylation.\",\n      \"evidence\": \"Chimeric minigene mutagenesis, RNA-EMSA, and RNA pulldown identifying DSE-binding proteins including TDP-43, PTB, and others\",\n      \"pmids\": [\"23554949\", \"23411391\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Long-distance element findings rely on a single minigene assay system without identification of the trans-acting factors that mediate their effects\",\n        \"The functional contribution of individual DSE-binding proteins (PTB, FBP1/2, nucleolin, vigilin) to PAS4 processing is not determined\",\n        \"Whether long-distance elements operate via chromatin looping, transcription kinetics, or another mechanism is unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"TDP-43 was identified as a post-transcriptional stabilizer of ADD2 mRNA, acting independently of polyadenylation/3′ processing, separating its function from the DSE-dependent cleavage mechanism at PAS4.\",\n      \"evidence\": \"TDP-43 knockdown in HeLa and HEK293 cells, RNA stability assays, chimeric minigenes, RNA-EMSA\",\n      \"pmids\": [\"25602706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The RNA element through which TDP-43 stabilizes ADD2 mRNA is not mapped\",\n        \"Whether TDP-43-dependent stabilization occurs in neurons and is relevant to the synaptic plasticity phenotype is untested\",\n        \"Whether TDP-43 loss-of-function in ALS/FTD contributes to disease through ADD2 downregulation is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of the alpha/beta/gamma-adducin heterocomplex, the specific phosphorylation events that toggle ADD2 between actin-capping and release states at synapses, and the in vivo significance of TDP-43-mediated ADD2 mRNA stabilization in neurons remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of the adducin heterocomplex exists\",\n        \"Site-specific phospho-mutant analysis of ADD2 in synaptic plasticity models is lacking\",\n        \"In vivo validation of TDP-43-dependent ADD2 regulation in brain tissue has not been performed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [],\n    \"complexes\": [\"adducin heterocomplex (alpha/beta/gamma)\"],\n    \"partners\": [\"ADD1\", \"ADD3\", \"TARDBP\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Beta-adducin (ADD2) is a cytoskeletal scaffolding protein that, together with alpha-adducin, forms heterodimers and tetramers to cap barbed ends of actin filaments, bundle actin, and recruit spectrin to actin filament ends and sides via its C-terminal MARCKS-related tail domain [PMID:3693401, PMID:7642559, PMID:8626479]. These activities are negatively regulated by PKC/PKA phosphorylation at Ser-713 and by Ca²⁺/calmodulin binding to the MARCKS domain, which controls adducin's membrane association and spectrin-actin lattice assembly [PMID:8810272, PMID:9679146]. Genetic ablation of ADD2 in mice causes hereditary spherocytosis with osmotically fragile erythrocytes and compensatory gamma-adducin upregulation, and separately produces deficits in hippocampal LTP, LTD, learning, and motor coordination, establishing essential roles in both erythrocyte membrane integrity and synaptic plasticity [PMID:10485892, PMID:19900187]. ADD2 mRNA stability is post-transcriptionally regulated by TDP-43 and brain-specific 3′ end processing elements, and adducin physically links the spectrin-actin junctional complex to GLUT1 at the erythrocyte plasma membrane [PMID:25602706, PMID:18347014].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"The first reconstitution of adducin activity established that alpha/beta adducin bundles actin, promotes spectrin–actin association independently of protein 4.1, and is negatively regulated by Ca²⁺/calmodulin, defining adducin as a regulated cytoskeletal scaffold.\",\n      \"evidence\": \"Purified human erythrocyte adducin characterized by sedimentation, electrophoresis, and morphologic assays\",\n      \"pmids\": [\"3693401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry and capping versus bundling contributions were not separated\",\n        \"In vivo relevance in intact erythrocytes not yet demonstrated\"\n      ]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Cloning and domain mapping of beta-adducin revealed a three-domain architecture (head–neck–tail) with a C-terminal MARCKS-related domain responsible for spectrin-actin interaction and predicted PKC phosphorylation sites, establishing the structural basis for regulated cytoskeletal function.\",\n      \"evidence\": \"cDNA sequencing, Northern blot tissue expression, rotary-shadowed EM of recombinant domains\",\n      \"pmids\": [\"1840603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Phosphorylation sites were predicted but not functionally validated\",\n        \"No high-resolution structure of the head or neck domain\"\n      ]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstration that adducin forms heterodimers/tetramers and that isolated C-terminal tail domains are sufficient for spectrin–actin recruitment resolved which portion of the molecule mediates the key scaffolding function.\",\n      \"evidence\": \"Cross-linking, proteolysis, blot-binding, and CD spectroscopy of recombinant tail domains\",\n      \"pmids\": [\"7642559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How head domain contributes to in vivo assembly remained unclear\",\n        \"No crystal or NMR structure of the tail–spectrin–actin ternary complex\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Quantitative barbed-end capping activity of adducin (Kcap ~100 nM) was defined, and this activity was shown to be inhibited by Ca²⁺/calmodulin; separately, Ser-713 of beta-adducin was identified as the shared PKA/PKC site whose phosphorylation reduces spectrin–actin affinity, providing a dual regulatory switch for adducin function.\",\n      \"evidence\": \"Pyrene-actin polymerization kinetics, site-directed mutagenesis, phosphopeptide mapping, spectrin–actin binding assays\",\n      \"pmids\": [\"8626479\", \"8810272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contributions of PKA vs PKC phosphorylation in vivo were unknown\",\n        \"Structural basis for how phosphorylation disrupts spectrin–actin binding unresolved\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"PKC phosphorylation of adducin's MARCKS domain was shown to abolish both barbed-end capping and spectrin recruitment in vitro and in vivo, and phospho-adducin was localized to dendritic spines and cell–cell contacts, expanding adducin's regulated role beyond erythrocytes to epithelial and neuronal cells.\",\n      \"evidence\": \"Pyrene-actin assays, phosphospecific antibody immunofluorescence, stable expression of phospho-dead alpha-adducin in MDCK cells\",\n      \"pmids\": [\"9679146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether beta-adducin phosphorylation produces identical in vivo phenotypes was not tested\",\n        \"Kinetics and reversibility of PKC regulation in neurons not characterized\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic ablation of beta-adducin in mice produced hereditary spherocytosis with osmotically fragile red cells and a compensatory 5-fold increase in gamma-adducin, proving ADD2 is essential for erythrocyte membrane skeletal integrity.\",\n      \"evidence\": \"Targeted deletion of exons 9–13 in mice; osmotic fragility assays, Western blot quantification of membrane adducin subunits\",\n      \"pmids\": [\"10485892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether gamma-adducin compensation is functionally equivalent was not determined\",\n        \"Human disease counterpart had not been established\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Expression of hypertensive adducin variants in renal epithelial cells impaired dopamine-stimulated Na⁺,K⁺-ATPase endocytosis via adaptin mu2 hyperphosphorylation, providing a mechanism linking adducin mutations to renal sodium retention and hypertension.\",\n      \"evidence\": \"Overexpression of rat/human variant adducin in OK cells, Na⁺,K⁺-ATPase activity and mu2 phosphorylation assays, co-IP\",\n      \"pmids\": [\"15528469\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding; not independently replicated\",\n        \"Which adducin subunit (alpha vs beta) is the primary driver in this pathway was unclear\",\n        \"In vivo renal phenotype not demonstrated in beta-adducin-specific models\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of a direct adducin–GLUT1 interaction placed adducin as a physical linker between the spectrin–actin junctional complex and the lipid bilayer, resolving a gap in understanding how the erythrocyte membrane skeleton attaches to integral membrane proteins.\",\n      \"evidence\": \"Surface labeling, co-immunoprecipitation, and vesicle proteomics from human erythrocyte membranes\",\n      \"pmids\": [\"18347014\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab co-IP; binding domain on adducin not mapped\",\n        \"Functional consequence of disrupting the adducin–GLUT1 link not tested\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Beta-adducin knockout mice exhibited impaired hippocampal LTP/LTD and behavioral deficits in learning and motor coordination, with dendritic localization of Add2 mRNA suggesting local translational regulation, establishing ADD2 as necessary for synaptic plasticity.\",\n      \"evidence\": \"Beta-adducin KO mice, field potential electrophysiology, Morris water maze and rotarod behavioral assays, in situ hybridization\",\n      \"pmids\": [\"19900187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism connecting adducin loss to LTP/LTD impairment not defined\",\n        \"Whether dendritic mRNA undergoes activity-dependent translation not tested\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Brain-specific polyadenylation of Add2 pre-mRNA was found to require a UG-rich downstream sequence element bound by TDP-43, PTB, and other RNA-binding proteins, plus long-distance cis elements, revealing a complex layer of tissue-specific post-transcriptional regulation.\",\n      \"evidence\": \"Chimeric minigene transfection and mutagenesis, RNA-EMSA, RNA pulldown with mass spectrometry\",\n      \"pmids\": [\"23554949\", \"23411391\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional contribution of each identified RBP to Add2 processing not individually tested\",\n        \"Whether these cis-elements regulate Add2 processing in primary neurons unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"TDP-43 was shown to stabilize Add2 mRNA post-transcriptionally rather than via 3′ end cleavage/polyadenylation, distinguishing its role from the DSE-binding complex identified earlier and linking TDP-43 pathology to cytoskeletal gene regulation.\",\n      \"evidence\": \"TDP-43 siRNA knockdown in HeLa and HEK293 cells, polyA tail length analysis, RNA-EMSA, co-IP with polyadenylation factors\",\n      \"pmids\": [\"25602706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether TDP-43 directly binds Add2 mRNA or acts via an intermediate is unknown\",\n        \"Relevance to TDP-43 proteinopathy (ALS/FTD) models not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No high-resolution structure of the adducin heterodimer or its ternary complex with spectrin and F-actin has been determined, the molecular mechanism by which adducin loss impairs synaptic plasticity remains undefined, and the human disease spectrum caused by ADD2 mutations is incompletely characterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No atomic-resolution structural model of adducin or its spectrin–actin complex\",\n        \"Molecular mechanism linking adducin to LTP/LTD induction not determined\",\n        \"Human Mendelian phenotype for ADD2 loss-of-function not established\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 2, 3, 5]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 6, 8]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\n      \"adducin alpha/beta heterodimer\",\n      \"spectrin-actin junctional complex\"\n    ],\n    \"partners\": [\n      \"ADD1\",\n      \"ADD3\",\n      \"SPTA1\",\n      \"SPTB\",\n      \"SLC2A1\",\n      \"TARDBP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}